stella
beta
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors — Stella
Home
/
Anatomic Stage IV Breast Cancer AJCC v8
/
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
View on ClinicalTrials.gov
Recruiting
Back to Anatomic Stage IV Breast Cancer AJCC v8 trials
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Trial locations
(1 site)
United States
Roswell Park Cancer Institute, Buffalo, New York